ESMO Calls for Cancer Care Integration in EU Global Health Resilience Initiative (GHRI) By Ogkologos - March 24, 2026 325 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge MOST POPULAR Getting Better Sleep When You Have Cancer-Related Insomnia: An Expert Q&A October 3, 2023 Neoadjuvant Followed by Adjuvant Pembrolizumab Prolongs Event-Free Survival Compared to Adjuvant... March 8, 2023 FDA Approves Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma July 12, 2022 Bowel Cancer Data Reinforce Need to Reduce Unnecessary Antibiotic Use [ESMO... July 2, 2021 Load more HOT NEWS Inavolisib Plus Palbociclib–Fulvestrant Prolongs PFS in Patients with PIK3CA-mutated, HR-positive, HER2-negative... Updated ROAR Analysis Confirms the Benefit of Dabrafenib Plus Trametinib in... ESMO 2024 Press Conference Working to Address Inequities in Cancer Care: 2021 ASCO Annual Meeting...
